Skip to main content

Table 2 Results of direct comparsions

From: Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis

Outcome

Treatment

No. of

studies

No. of

patients

HR/OR(95%CI)

Heterogeneity

I2(%)

P

OS

nCRTS-ENI vs S alone

6

432

HR 0.70(0.54–0.92)

8

0.37

nCRTS-IFI vs S alone

10

2228

HR 0.74(0.66–0.83)

10

0.35

nCTS vs S alone

13

2526

HR 0.86(0.76–0.98)

40

0.06

LR

nCRTS-ENI vs S alone

4

288

OR 0.69(0.35–1.35)

46

0.13

nCRTS-IFI vs S alone

6

1221

OR 0.43(0.33–0.57)

0

0.50

nCTS vs S alone

7

2176

OR 0.79(0.62–0.99)

26

0.23

DM

nCRTS-ENI vs S alone

4

288

OR 0.87(0.35–2.21)

57

0.07

nCRTS-IFI vs S alone

6

1221

OR 0.79(0.62–1.00)

0

0.43

nCTS vs S alone

7

2176

OR 0.83(0.68–1.01)

37

0.15

R0 resection

nCRTS-ENI vs S alone

2

155

OR 5.75(2.19–15.13)

0

0.61

nCRTS-IFI vs S alone

4

1119

OR 5.17(1.95–13.67)

68

0.02

nCTS vs S alone

7

1705

OR 1.71(1.39–2.10)

0

0.75

nCRTS-ENI vs nCT

2

166

OR 4.71(1.98–11.24)

0

0.85

POM

nCRTS-ENI vs S alone

5

324

OR 1.52(0.66–3.52)

0

0.85

nCRTS-IFI vs S alone

8

1704

OR 1.79(1.14–2.82)

27

0.21

nCTS vs S alone

11

2453

OR 1.02(0.75–1.38)

0

0.87

  1. Abbreviations: No. Number, HR Hazard ratio, CI Confidence interval, OR Odds ratio, OS Overall survival, LR Locoregional recurrence, DM Distant metastases, POM Post-operative mortality, nCRTS Neoadjuvant chemoradiotherapy plus surgery, nCTS Neoadjuvant chemotherapy plus surgery, S Surgery, ENI Elective nodal irradiation, IFI Involved-field irradiation
  2. Significant results are in bold